Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:28:41 EST Sun 15 Feb 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:PLSE - PULSE BIOSCIENCES INC - https://investors.pulsebiosciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PLSE - Q0.122.26·31.320.123.01-0.39-1.7309.57,0933,47023.55  24.87  22.977926.27  12.5619:59:55Feb 0515 min RT 2¢

Recent Trades - Last 10 of 3470
Time ETExPriceChangeVolume
19:59:55Q23.0986-0.3014100
18:43:59Q23.08-0.322
18:30:15Q23.0509-0.349110
18:08:04Q23.06-0.343
18:08:04Q23.09-0.312
17:55:03Q23.0987-0.301390
17:30:18Q23.11-0.29300
17:23:45Q23.1097-0.2903167
16:52:41Q23.11-0.291
16:51:42Q23.11-0.291

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 19:00U:PLSENews ReleasePulse Biosciences Presents Late-Breaking Data from nPulse(TM) Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
2026-02-04 16:05U:PLSENews ReleasePulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
2026-02-03 07:00U:PLSENews ReleasePulse Biosciences' nPulse(TM) Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
2026-01-09 07:00U:PLSENews ReleasePulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
2026-01-06 07:00U:PLSENews ReleasePulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
2025-12-29 16:05U:PLSENews ReleasePulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-19 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-18 07:00U:PLSENews ReleasePulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
2025-12-09 07:00U:PLSENews ReleasePulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse(TM) Technology
2025-11-21 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-11-06 16:05U:PLSENews ReleasePulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
2025-11-05 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
2025-10-24 07:00U:PLSENews ReleasePulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
2025-10-22 16:05U:PLSENews ReleasePulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
2025-10-16 07:00U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-10-10 07:00U:PLSENews ReleasePulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse(TM) Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
2025-10-07 07:00U:PLSENews ReleasePulse Biosciences Announces Clinical Data Highlighting its nPulse(TM) Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
2025-09-17 07:00U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-09-10 07:00U:PLSENews ReleasePulse Biosciences' nPulse(TM) Technology to be Featured at the American Thyroid Association 2025 Annual Meeting
2025-09-08 07:00U:PLSENews ReleasePulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation